PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,463
+724.5%
25,317
+183.3%
0.01%
+350.0%
Q2 2023$420
+12.0%
8,9380.0%0.00%0.0%
Q1 2023$375
+10.0%
8,9380.0%0.00%0.0%
Q4 2022$341
-99.9%
8,9380.0%0.00%0.0%
Q3 2022$350,000
+21.1%
8,9380.0%0.00%0.0%
Q2 2022$289,000
-2.4%
8,9380.0%0.00%
+100.0%
Q1 2022$296,000
-22.1%
8,9380.0%0.00%
-50.0%
Q4 2021$380,000
-4.0%
8,9380.0%0.00%0.0%
Q3 2021$396,000
-22.0%
8,9380.0%0.00%0.0%
Q2 2021$508,000
-24.1%
8,9380.0%0.00%
-33.3%
Q1 2021$669,000
-13.5%
8,9380.0%0.00%
-25.0%
Q4 2020$773,000
+41.6%
8,9380.0%0.00%
+33.3%
Q3 2020$546,000
+46.8%
8,9380.0%0.00%
+50.0%
Q2 2020$372,000
+44.7%
8,9380.0%0.00%0.0%
Q1 2020$257,000
-55.5%
8,938
+11.9%
0.00%
-33.3%
Q4 2019$577,000
-48.5%
7,9870.0%0.00%
-57.1%
Q3 2019$1,120,000
-23.4%
7,9870.0%0.01%
-22.2%
Q2 2019$1,462,000
-4.4%
7,987
-16.9%
0.01%
-10.0%
Q1 2019$1,530,000
+130.1%
9,617
+38.4%
0.01%
+100.0%
Q4 2018$665,000
-32.4%
6,947
-0.3%
0.01%
-16.7%
Q3 2018$984,000
+32.1%
6,966
+46.4%
0.01%
+20.0%
Q2 2018$745,000
+50.5%
4,757
+54.9%
0.01%
+66.7%
Q1 2018$495,000
-2.2%
3,0720.0%0.00%0.0%
Q4 2017$506,0003,0720.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders